Ads
related to: zoetis cerenia dosing chart acute vomiting and constipation medication treatment
Search results
Results From The WOW.Com Content Network
Maropitant (INN; [3] brand name: Cerenia, used as maropitant citrate , is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs [4] [5] and in 2012, for cats. [6]
[3] [4] [5] Librela is sponsored by Zoetis. [ 5 ] [ 6 ] The most common side effects include increased blood urea nitrogen (an indicator of kidney function), urinary tract infection, bacterial skin infection, skin irritation (dermatitis), rash (erythema) or pain at injection site, vomiting (emesis), and weight loss (anorexia).
Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [ 5 ] [ 4 ] [ 6 ] The company was a subsidiary of Pfizer , [ 7 ] the world's largest drug maker , but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
Sales in its companion animal segment that sells vaccines and treatments for dogs, cats and horses rose 10.7% to $1.65 billion. Zoetis lifts 2024 results forecasts on strong demand for pet ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
5-HT 3 antagonists are most effective in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV), especially that caused by highly emetogenic drugs such as cisplatin; when used for this purpose, they may be given alone or, more frequently, with a glucocorticoid, usually dexamethasone.
Interest surrounding glucagon-like peptide 1 agonists , a class of type 2 diabetes drugs that help blood sugar management and may lead to weight loss, continues to grow. With more medications ...
Therapeutic treatment for the prodromal phase, characterized by the anticipation of an episode, consists of sumatriptan (nasal or oral) an anti-migraine medication, anti-inflammatory drugs to reduce abdominal pain, and possible anti-emetic drugs. These options may be helpful in preventing an episode or reducing the severity of an attack. [12] [13]